Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Apraglutide and N-acetylcysteine (NAC) show promise in reducing cytarabine's harmful effects on organs.

Cystaselenonine causes temporary hair loss in mice by interfering with hair growth.

Promising cancer treatments were found, but the manufacturer closed.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Topical IKKα inhibitors may help prevent CCS tumours.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Sulfur-containing radioprotectors can protect hair from X-ray damage if given before exposure but worsen damage if given after.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

The cosmetic product improved melasma and skin quality without causing irritation.

Combining ciclosporin and simvastatin can cause severe kidney damage.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

The new compound may be a safer alternative to finasteride for prostate protection.

Albendazole and praziquantel can cause severe side effects, especially with prolonged use or liver issues.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Targeted protein degradation could improve cancer treatment by effectively targeting the Wnt pathway.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.